Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
These trade-offs can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. That said, here is one small-cap stock that could be the next 100 bagger and two best left ignored.
Two Small-Cap Stocks to Sell:
PacBio (PACB)
Market Cap: $462.8 million
Pioneering what scientists call "HiFi long-read sequencing," recognized as Nature Methods' method of the year for 2022, Pacific Biosciences (NASDAQ:PACB) develops advanced DNA sequencing systems that enable scientists and researchers to analyze genomes with unprecedented accuracy and completeness.
Why Does PACB Worry Us?
- Annual sales declines of 10.6% for the past two years show its products and services struggled to connect with the market during this cycle
- Cash-burning tendencies make us wonder if it can sustainably generate shareholder value
- Unprofitable operations could lead to additional rounds of dilutive equity financing if the credit window closes
PacBio’s stock price of $1.49 implies a valuation ratio of 2.7x forward price-to-sales. If you’re considering PACB for your portfolio, see our FREE research report to learn more.
TFS Financial (TFSL)
Market Cap: $5.14 billion
Tracing its roots back to 1938 during the Great Depression era when savings and loans were vital to homeownership, TFS Financial (NASDAQ:TFSL) is a savings and loan holding company that provides mortgage lending, deposit services, and other retail banking products primarily in Ohio and Florida.
Why Should You Sell TFSL?
- Annual net interest income growth of 3.9% over the last five years was below our standards for the banking sector
- Net interest margin of 1.7% is well below other banks, signaling its loans aren’t very profitable
- Earnings per share lagged its peers over the last five years as they only grew by 2% annually
At $18.43 per share, TFS Financial trades at 2.6x forward P/B. Dive into our free research report to see why there are better opportunities than TFSL.
One Small-Cap Stock to Watch:
Cadre (CDRE)
Market Cap: $1.29 billion
Originally known as Safariland, Cadre (NYSE:CDRE) specializes in manufacturing and distributing safety and survivability equipment for first responders.
Why Do We Like CDRE?
- Annual revenue growth of 11.8% over the last two years was superb and indicates its market share increased during this cycle
- Demand for the next 12 months is expected to accelerate above its two-year trend as Wall Street forecasts robust revenue growth of 17.6%
- Operating profits increased over the last five years as the company gained some leverage on its fixed costs and became more efficient
Cadre is trading at $30.24 per share, or 21.5x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
Stocks We Like Even More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.